You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

List of Excipients in API prednisolone sodium phosphate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing prednisolone sodium phosphate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Seton Pharmaceuticals LLC PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate 13925-166 EDETATE DISODIUM
Seton Pharmaceuticals LLC PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate 13925-166 METHYLPARABEN
Seton Pharmaceuticals LLC PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate 13925-166 RASPBERRY
Seton Pharmaceuticals LLC PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate 13925-166 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing prednisolone sodium phosphate

Company Ingredient NDC Excipient
PAI Holdings LLC prednisolone sodium phosphate 0121-0759 EDETATE DISODIUM
PAI Holdings LLC prednisolone sodium phosphate 0121-0759 GLYCERIN
PAI Holdings LLC prednisolone sodium phosphate 0121-0759 HIGH FRUCTOSE CORN SYRUP
PAI Holdings LLC prednisolone sodium phosphate 0121-0759 HYDROXYETHYL CELLULOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for prednisolone sodium phosphate

Excipient focus: ALCOHOL

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CORN SYRUP

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC POTASSIUM PHOSPHATE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

prednisolone sodium phosphate drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
PAI Holdings LLC prednisolone sodium phosphate 0121-0759
Pharmaceutical Associates Inc prednisolone sodium phosphate 0121-0773
Pharmaceutical Associates Inc prednisolone sodium phosphate 0121-0777
Pharmaceutical Associates Inc prednisolone sodium phosphate 0121-0902
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLCELLULOSES

Excipient focus: FRUCTOSE

Excipient focus: GLYCERIN

Excipient focus: HIGH FRUCTOSE CORN SYRUP

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: MONOBASIC POTASSIUM PHOSPHATE

Excipient focus: MONOPOTASSIUM PHOSPHITE

Excipient focus: POTASSIUM PHOSPHATE, DIBASIC

Excipient focus: POTASSIUM PHOSPHATE, MONOBASIC

Excipient focus: RASPBERRY

Excipient focus: SACCHARIN SODIUM

Excipient focus: SACCHARIN SODIUM DIHYDRATE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: SORBITOL

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group